Science
Mechanism of Action
Depending on its specific molecular structure, DECAPEPTIDE-50 can operate through different mechanisms. One form, a bFGF-related decapeptide, actively promotes the proliferation and migratory behavior of melanocytes in depigmented areas, thereby stimulating re-pigmentation. Another form, such as Decapeptide-12, functions as a potent tyrosinase inhibitor, directly targeting the enzyme critical for melanin synthesis to reduce hyperpigmentation. Additionally, Decapeptide-12 may contribute to improved skin health through anti-inflammatory properties, stimulation of collagen production, and enhancement of the skin's natural barrier function.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 A 0.1% topical application of a bFGF-related decapeptide achieved re-pigmentation exceeding 75% in 79% of vitiligo patients over 5 months, demonstrating superior efficacy to betamethasone valerate 0.1%.
- 02 A 0.01% Decapeptide-12 formulated in a cream base reduced recalcitrant melasma by 40-50% after 12-16 weeks of twice-daily application, proving safer and more effective than hydroquinone.
Transparency
Dusting Analysis
No specific data regarding 'dusting' or common misuse concentrations for DECAPEPTIDE-50 were found in the available research.
The Formula
Formulation
Stability
Decapeptide-12, a basic peptide, demonstrates optimal stability when dissolved in buffers with a pH between 4.0 and 6.0, approximately two units below its estimated isoelectric point (pI 10.2-10.5) to prevent precipitation. Stability can be significantly enhanced through pH adjustment, the use of citrate or acetate buffers, optimizing salt concentrations to below 50 mM, decreasing peptide concentration, incorporating stabilizing excipients (e.g., sugars like sucrose/trehalose, polyols like mannitol/sorbitol, or amino acids like arginine/glycine), and maintaining consistent cool storage temperatures (2-8°C). Glycosylated peptides may offer extended shelf life in solution.
Safety
Safety Profile
While DECAPEPTIDE-50 itself has not undergone specific safety assessment by CIR, SCCS, or FDA, general peptide classes are widely considered safe for cosmetic use. Clinical studies for a decapeptide used in vitiligo reported excellent tolerability in 96.92% of patients, with a favorable safety profile. Minor side effects such as mild skin irritation, dry skin, or a burning sensation were noted in a small percentage. Decapeptide-12 is reported to be safer than hydroquinone. Data regarding pregnancy safety is not available in the provided research.
Your Skin
Skin Compatibility
Our Assessment
Verdict
DECAPEPTIDE-50 offers a multi-faceted approach to skin health, notably addressing both hypo- and hyperpigmentation with strong clinical backing and a favorable safety profile.
Related
Similar Ingredients
Finding similar ingredients…